A global perspective on early and post-trial access, real-world data, and regulatory innovation
Insights from our flagship Clinigen Insights February 2025 conference, now available in a five-part virtual series.
As the world leader in providing access to innovative medicines, we’re proud to present the virtual insights series — a high-impact series, drawing on the key insights and themes from our in-person event in Windsor, UK (February 2025).
Through five expert-led webinars, we explore the evolving access landscape across key markets and mechanisms — from post-trial access and early access schemes to real-world data and HTA readiness.
This is essential content for professionals in:
- The managed access space
- Regulatory affairs
- Real-world data
- Policy and advocacy
- Market access
- Clinical operations
Each session is 60 minutes and free to attend. Click through to register and learn more about each session.
Explore the sessions
Session 1: Real-world data: the French landscape and global impact Date: Monday, 12 May 2025 at 3:00 PM - 4:00 PM BST | |
Session 2: The phenomenal increase in post-trial access (PTA) Date: Tuesday, 13 May 2025 at 3:00 PM - 4:00 PM BST | |
| Session 3: UK early access to medicines scheme – 10 years on Reflecting on a decade of EAMS: evolution, impact, and future potential. Guest speaker - Stephen Maddocks Date: Wednesday, 14 May 2025 at 3:00 PM - 4:00 PM BST | |
| Session 4: Can data from managed access support HTA evaluation? Using access program data to inform HTA decisions and accelerate uptake. Guest speaker - Prof. Marc Bardou Date: Thursday, 15 May 2025 at 3:00 PM - 4:00 PM BST | |
| Session 5: How to operationalise the French early access system – the rules and the exceptions A practical guide to navigating France’s early access pathway Date: Friday, 16 May 2025 at 3:00 PM - 4:00 PM BST |